Figure 2From: SULFs in human neoplasia: implication as progression and prognosis factorsSULF2 expression in the 7 groups of the molecular classification of multiple myeloma. The expression of SULF2 in LR-TT2 cohort was investigated in the 7 groups of the molecular classification of multiple myeloma. PR: proliferation, LB: low bone disease, MS: MMSET, HY: hyperdiploid, CD1: Cyclin D1, CD2: Cyclin D2, MF: MAF.Back to article page